Skip to main content

Ogilvy Health’s Kim Johnson Named a PharmaVoice 100 Honoree

Global CEO, Johnson to Serve as a Panelist During the Celebration’s Opening Session

Kim Johnson: Global CEO – Ogilvy Health

2022 PharmaVoice 100 Honoree
2022 PharmaVoice 100 Honoree

NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) — Ogilvy Health part of Ogilvy (www.ogilvy.com), today announced Kim Johnson, the agency’s Global CEO, has been named to the prestigious 2022 PharmaVoice 100, a recognition of the 100 most inspiring people in the life-sciences industry.

Each year the PharmaVoice 100, established in 2005 by premier healthcare communications publication, PharmaVoice, honors select individuals for their inspirational contributions to the life sciences industry. The distinguished honorees are selected based on comprehensive testimonial essays detailing how nominated individuals have motivated and effected positive change within the healthcare marketing industry.

Kim, previously recognized with a PharmaVoice 100 designation in 2015 in the “Commanders & Chiefs” category, was named this year to the “Legacy Leaders” category for her illustrious healthcare marketing career of more than 25 years working on blockbuster campaigns, striving for greater health equity and patient empowerment, and harnessing the power of digital health. This award follows other recent, notable recognitions for Kim, as she was named one of PRWeek’s Top 30 Health Influencers in 2021 and was inducted into MM+M’s Women of Distinction class earlier this year. 

Ogilvy Health’s Global CEO, Kim Johnson said: “I’m humbled by this recognition among the many talented and dedicated professionals working in life sciences.  I’ve been so fortunate to work in an industry where I regularly feel we are at the verge of something truly great.”  

This year’s PharmaVoice 100 recipients will be honored on September 15 at the “PharmaVoice 100 Celebration — the Next Era of Leadership” — a virtual full-day event featuring engaging and interactive discussions. Kim will serve as a panelist at the event’s opening session, “CEO Roundtable: Navigating Uncharted Waters.”

For those who would like to attend, you can register for the free event here. To learn more about Kim, her career accomplishments, and her ongoing successes as she continues to drive brand growth for her clients, elevating Ogilvy Health to new heights along the way, her PharmaVoice 100 write-up can be found here.

About Ogilvy Health
Ogilvy Health is focused on driving superior outcomes in the ever-changing healthcare environment, an increasingly complex and evolving marketplace. We inspire brands and people to impact the world by keeping our audiences’ health and wellness needs at the center of every touchpoint. Ogilvy Health delivers insight, creativity, innovation, and engagement solutions for all healthcare stakeholders, patients, and consumers across the healthcare continuum. Through borderless creativity—operating, innovating, and creating at the intersection of talent and capabilities— Advertising, Experience, Public Relations, Health, and Consulting work fluidly across 131 offices in 93 countries to bring forth world-class creative solutions for our clients. For more information, visit OgilvyHealth.com, or follow Ogilvy Health on Twitter, LinkedIn, Facebook, and Instagram.

For more information contact:Beth Paulino / beth.paulino@ogilvy.com
 Kerianne Slattery / kerianne.slattery@ogilvy.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/04067144-18fd-4b61-8968-0d0d734af223

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.